Robert J. Flanagan, Director at Sagent Pharmaceuticals, Inc. (SGNT), bought 2,000 shares at $19.95 ($40K) on 2011-08-15, disclosed to the SEC on 2011-08-17.
Open-market purchase of $40k SGNT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.95 | 1,000 | $20K | 50.3% |
| 2 | $19.75 | 1,000 | $20K | 49.7% |
| Total | $19.85 avg | 2,000 | $40K | 100% |
| Filing → |
| SGNT | SELL | 2014-10-08 | $505K | — | Filing → |
| SGNT | SELL | 2014-09-25 | $480K | — | Filing → |
| SGNT | SELL | 2014-09-12 | $453K | — | Filing → |